Maynard Um
-
-
-
-
-
-
-
RBC Capital Downgrades Bio-Techne Corp. (TECH) to Sector Perform
-
-
-
-
-
-
-
TD Cowen Highlights Bio-Techne Corp. (TECH) as a Best Smidcap Idea
-
-
-
-
-
-
-
Evercore: ' Latest Survey Work Positions 2026 As Better Year For Biopharma Spending'
-
-
-
-
-
-
-
Benchmark Reiterates Buy Rating on Bio-Techne Corp. (TECH)
-
-
-
-
-
-
-
Bio-Techne expands Oxford Nanopore partnership through 2032
-
-
-
-
-
-
-
Bio-Techne technology used in FDA-approved gene therapy ZEVASKYN
-
-
-
-
-
-
-
Wells Fargo Starts Bio-Techne Corp. (TECH) at Overweight
-
453,569 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

